国际西方放疗指南在低中收入国家宫颈癌管理中的适用性:地中海地区南北边界国家的比较调查
该横断面调查研究通过在线问卷比较法国(高收入国家)与摩洛哥(低中收入国家)宫颈癌放疗实践,共分析77名参与者(摩洛哥45人、法国32人)的诊断、治疗和影像实践。结果显示两国在HPV疫苗接种覆盖率、MRI和PET-CT使用、IB1/IB2期治疗选择及近距离放疗技术应用上存在显著差异,但摩洛哥团队在资源有限条件下仍能较好适应多数西方指南。
要点
- 法国MRI用于近距离放疗前比例(90%)显著高于摩洛哥(25%)。
- 法国PET-CT用于腹主动脉淋巴结分期比例(97%)远高于摩洛哥(59%)。
- 摩洛哥腔内联合组织间插植近距离放疗使用率(9%)低于法国(64%)。
核心结论
- 摩洛哥团队在资源有限条件下能够适应多数西方宫颈癌指南,但仍需基础设施发展和持续培训以支持临床实践的长期协调。
研究设计与样本
- 横断面调查研究,使用在线问卷分发至法国和摩洛哥参与宫颈癌诊疗的专家,共分析77名参与者(摩洛哥45人、法国32人),以女性为主,年龄40至49岁。
主要发现
- 86.8%的受访者报告其患者未接种HPV疫苗。
- 近距离放疗前MRI使用率法国为90%,摩洛哥为25%。
- 腹主动脉淋巴结分期PET-CT使用率法国为97%,摩洛哥为59%。
- IB1和IB2期术前近距离放疗摩洛哥更常用(34% vs 16%)。
- 摩洛哥78%病例达到高危临床靶区D90剂量>85 Gy。
关键数值与推荐
- 图像引导近距离放疗在两国均系统使用,但腔内联合组织间插植应用法国更频繁(64% vs 9%)。
- 摩洛哥剂量学结果总体满意,78%病例高危临床靶区D90>85 Gy,依托容积旋转调强放疗和CT计划。
临床怎么用
- 应重视提高HPV疫苗接种覆盖率、改善MRI和PET-CT可及性、优化高剂量率近距离放疗使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This comparative study evaluates the applicability of international radiation therapy guidelines in the management of cervical cancer between high-income countries and low- and middle-income countries (LMICs). Understanding differences in clinical practice is essential to identify gaps and areas for improvement in LMICs. METHODS AND MATERIALS: A cross-sectional survey was conducted using an online questionnaire distributed among specialists involved in cervical cancer care from France (high-income countries) and Morocco (LMIC). Responses from 77 participants (45 from Morocco, 32 from France), predominantly females aged 40 to 49 years, were analyzed to assess diagnostic, therapeutic, and imaging practices. RESULTS: Significant differences were observed between the 2 countries. Human papillomavirus vaccination coverage was low, with 86.8% of respondents reporting that their patients were not vaccinated. Magnetic resonance imaging use before brachytherapy (BCT) was more frequent in France (90%) compared with Morocco (25%). Positron emission tomography-computed tomography for lumbar-aortic staging was widely used in France (97%) versus 59% in Morocco.Therapeutic approaches for the International Federation of Gynecology and Obstetrics stages IB1 and IB2 varied, with Morocco favoring preoperative BCT more often (34% vs 16%). Image-guided brachytherapy was systematically used in both countries, but combined intracavitary and interstitial applications were more frequent in France (64% vs 9%). In Morocco, dosimetric outcomes were generally satisfactory, with a D90 dose to the high-risk clinical target volume >85 Gy achieved in 78% of cases, supported by volumetric modulated arc therapy and computed tomography-based planning. CONCLUSIONS: Our findings highlight the ability of Moroccan teams to adapt their practice to most Western guidelines for cervical cancer, despite resource limitations. However, there is a crucial need for infrastructure development and continuous training to support long-term harmonization of clinical practice. Significant efforts are also required to improve human papillomavirus vaccination coverage, enhance access to magnetic resonance imaging and positron emission tomography-computed tomography, and optimize the use of high-dose-rate BCT.
引用
- Samlali H, Chargari C, Flandin I, et al. International Western Radiation Therapy Guidelines Applicability in Low- and Middle-Income Countries for Cervical Cancer Management: A Comparative Survey Example from South and North Border of the Mediterranean Area Countries. Adv Radiat Oncol. 2026. PMID: 42761707. doi:10.1016/j.adro.2026.102154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。